image

July 2008: Odense University Hospital and the University of Southern Denmark sell their shares in Hypo-Safe A/S. Read the article in Berlingske Tidende and see the reportage in TV2

June 2008: Hypo-Safe presents scientific results on clinical diabetes trials at the 68th American Diabetes Association yearly meeting in San Francisco June 2008. See exebition Poster

More news

image
 
image


image


Hypo-Safe is pioneering cognitive technologies designed to help and empower people. We create tiny implants that monitor brain activity to convey relevant information and issue alerts. Our devices can be used for medical or therapeutic purposes or for enhancement.

We are currently clinically testing the world’s first EEG monitoring device for diabetics unable to feel and respond to a critical low blood sugar level. By warning the carrier before a critically low blood sugar level is reached the device prevents hypoglycemia with potential fatal consequences.

Hypo-Safe is continually exploring new applications of our core technology. We will proudly announce when we have news to break about additional avenues.

More on our technology